STAA241220P27500
- 2.20
- 0.000.00%
Staar Surgical Newsroom
Needham Maintains Staar Surgical(STAA.US) With Hold Rating
Needham Sticks to Its Hold Rating for Staar Surgical (STAA)
BTIG Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $39
BTIG Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $39
Staar Surgical (STAA) Receives a Buy From BTIG
Broadwood Partners Buys Over $1.94 Million in Staar Surgical Stock
Mizuho Securities Maintains Staar Surgical(STAA.US) With Buy Rating, Announces Target Price $45
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Staar Surgical Analyst Ratings
CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Cuts Target Price to $28
Express News | STAAR Surgical Co : Canaccord Genuity Cuts Target Price to $28 From $31
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley Maintains Staar Surgical(STAA.US) With Sell Rating, Cuts Target Price to $23
STAAR Surgical's (NASDAQ:STAA) Earnings Have Declined Over Three Years, Contributing to Shareholders 71% Loss
STAAR Surgical to Participate in BTIG Ophthalmology Day
Implied Volatility Surging for STAAR Surgical (STAA) Stock Options
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $38
BTIG Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $49
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $42